Ramipril: A Review of its Use in Preventing Cardiovascular Outcomes in High-Risk Patients

Author： Anderson Vanessa R. Perry Caroline M. Robinson Dean M.

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.6, Iss.6, 2006-01, pp. : 417-432

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ramipril: A Review of its Use in the Prevention of Cardiovascular Outcomes

By Warner G.T. Perry C.M.

Drugs, Vol. 62, Iss. 9, 2002-01 ,pp. : 1381-1405

Adis International

Access to resources Recommend Favorite

Tolerability of Ramipril 10 mg/day in High-Risk Cardiovascular Chinese Patients

By Wu N. Zhu J.R. Chen K.A.

Clinical Drug Investigation, Vol. 22, Iss. 11, 2002-01 ,pp. : 771-781

Adis International

Access to resources Recommend Favorite

Cardiovascular Outcomes in High-Risk Patients without Heart Failure Treated with ARBs: A Systematic Review and Meta-Analysis

By Khalaf Mohamad M. Al

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 1, 2009-01 ,pp. : 29-43

Adis International

Access to resources Recommend Favorite

Ramipril cost effective in patients at high risk for cardiovascular events

Inpharma, Vol. 1, Iss. 1460, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Ramipril cost effective in patients at high risk for cardiovascular events

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 464, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite